Immunogenicity of COVID-19 vaccines in lung cancer patients

LUNG CANCER(2023)

引用 0|浏览14
暂无评分
摘要
•Lung cancer patients have higher risk of SARS-CoV-2 infection and severe complications.•Evaluating safety and immunogenicity of COVID-19 vaccine in 1973 lung cancer patients.•Non-post-authorization study, prospective of IgG analysis by immunoassay.•These patients can safely achieve a strong immune response against SARS-CoV-2.
更多
查看译文
关键词
Lung cancer,SARS-CoV-2,COVID-19,Vaccine,Immune response,Neutralizing antibodies
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要